Summary. The 
Introduction
With advancing gestation there is an increase in the extensibility of the cervix of rats (Harkness & Nightingale, 1962; Hollingsworth, Isherwood & Foster, 1979a) , ewes (Fitzpatrick, 1977b;  Stys, Clewell & Meschia, 1978) and women (Conrad & Ueland, 1976) . The hormonal control of these changes is uncertain but could involve decreased plasma progesterone concentrations and/or increased plasma oestrogen, relaxin or prostaglandin concentrations (Fitzpatrick, 1977a, b; Hollingsworth et al, 1979a) . Several prostaglandins are able to soften the human cervix when used to induce abortion or labour at term and when given by a variety of routes, including intracervically, without necessarily inducing uterine contractions (see MacKenzie & Embrey, 1977) . The site and mechanism of action of the prostaglandins in producing this effect are uncertain.
The objectives of the present experiments were to determine whether prostaglandin (PG) F2a and E-2 could increase cervical extensibility in the late pregnant rat and to elucidate the site and mechanism of action. As it is known that PGF-2a can act on the ovary of the pregnant rat to decrease progesterone secretion (Fuchs, Mok & Sundaram, 1974; Buckle & Nathanielsz, 1975) this was investigated as a possible mechanism. Preliminary results have been published (Hollingsworth, Isherwood & Gallimore, 1979b) .
Materials and Methods
Primigravid Sprague-Dawley rats (300-450 g), of known gestational age (day of finding copulation plug = Day 1), were housed in a daily 13-h light period (07:00-20:00 h). After treat¬ ment of the rats (see Table 1 ) each was killed and the cervix removed. Cervical wet weight, weight of total products of conception and numbers of live and dead fetuses per litter were routinely determined (Hollingsworth et al, 1979a (1979a) . PGF-2a had no effect, but PGE-2 still produced an increase in extensibility.
PGF-2a had no effect on fetal survival when given alone or with progesterone. Of the 13 pregnant rats ovariectomized and given steroids plus 7 had fewer than 3 living fetuses per litter. Cervical extensibility in these 7 rats with mostly dead fetuses (2-7 + 0-6 min-1) did not differ from that (3-1 ±0-7 min-1) in the 6 rats with mostly living fetuses. PGE-2 (5 mg/kg) produced a few fetal deaths when given alone or when given with progesterone. The ovariectomized, steroid-treated rats given PGE-2 had normal living fetuses.
Prostaglandins in vitro
The extensibility of cervix on Day 18 pregnant rats in the presence of and after 30 min preincubation in PGF-2<x (10-5 m) was 8-5 ± 0-6 min-1 and in PGE-2 (10-5 m) was 5-5 ± 0-6 min-1. These values were not different from those of the respective saline (7-2 ± 0-5 min-1) and ethanol (5-9 ± 0-9 min-1) controls (n = 6-9).
Discussion
We have used an objective method to show that PGF-2a and PGE-2 given in vivo can increase cervical extensibility in the late pregnant rat. This agrees with the finding of increased cervical compliance with the prostaglandin analogue, cloprostenol, in the goat (Fitzpatrick, 1977b) , and the subjective observation of increased cervical softening after administration of PGF-2a and PGE-2 in the sheep (Fitzpatrick, 1977a) , As PGE-2 was able to increase cervical extensibility in ovariectomized, steroid-treated rats an extraovarian site of action must be considered. This effect of PGE-2 was not antagonized by progesterone, suggesting that PGE-2 was not acting by producing a fall in progesterone secretion. PGE-2 could be acting directly on the cervical connective tissue. Fitzpatrick (1977a) has described local areas of softening of the sheep cervix, adjacent to the cannula tip, following intra-cervical infusions of PGF-2a or PGE-2. Conrad & Ueland (1976) observed increased stretch modulus of isolated human cervical strips within 10 min of incubation with high concen¬ trations (10-6 g/ml) of PGE-2. The lack of effect of high concentrations of PGE-2 in vitro on the extensibility of the rat cervix does not support a direct action in this species but it is possible that the period of incubation was too short.
The mechanism(s) of the fetotoxicity with PGF-2a and PGE-2 cannot be deduced from the present results but may include increased uterine, motility. The lack of correlation between feto¬ toxicity and increased cervical extensibility suggests that the latter is not related to greater uterine motility.
The lack of effect of PGF-2a in ovariectomized rats suggests an intermediate, ovarian site of action for this PG. It is well established that PGF-2a, in the dose range used and at this time of pregnancy in the rat, will result in a rapid and sustained fall in plasma progesterone concen¬ trations Buckle & Nathanielsz, 1975) . For this reason, treatments were given on Day 18 of pregnancy. As the increase in cervical extensibility following PGF-2a was antagonized by progesterone it is suggested that the cervical action of PGF-2a involves a decrease in ovarian progesterone secretion. This may not be the only mechanism as progesterone itself did not significantly decrease extensibility and a progesterone-withdrawal treatment did not increase extensibility (Hollingsworth et al, 1979a (Anderson & Long, 1978) . Immunochemical techniques suggest that relaxin is stored in the same cells that synthesize progesterone in pig corpora lutea (Larkin, Fields & Oliver, 1977; Kendall, Plopper & Bryant-Greenwood, 1978) and in the late pregnant pig, PGF-2a produces a rapid release of relaxin (Sherwood, Chang, BeVier, Diehl & Dziuk, 1976) . 
